These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 35476994)

  • 1. Extensive characterization of HIV-1 reservoirs reveals links to plasma viremia before and during analytical treatment interruption.
    Cole B; Lambrechts L; Boyer Z; Noppe Y; De Scheerder MA; Eden JS; Vrancken B; Schlub TE; McLaughlin S; Frenkel LM; Palmer S; Vandekerckhove L
    Cell Rep; 2022 Apr; 39(4):110739. PubMed ID: 35476994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discordance between HIV-1 Population in Plasma at Rebound after Structured Treatment Interruption and Archived Provirus Population in Peripheral Blood Mononuclear Cells.
    Hendricks CM; Cash MN; Tagliamonte MS; Riva A; Brander C; Llano A; Salemi M; Stevenson M; Mavian C
    Microbiol Spectr; 2022 Aug; 10(4):e0135322. PubMed ID: 35699458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of Intact Proviruses in Blood and Lymph Node from HIV-Infected Individuals Undergoing Analytical Treatment Interruption.
    Vibholm LK; Lorenzi JCC; Pai JA; Cohen YZ; Oliveira TY; Barton JP; Garcia Noceda M; Lu CL; Ablanedo-Terrazas Y; Del Rio Estrada PM; Reyes-Teran G; Tolstrup M; Denton PW; Damsgaard T; Søgaard OS; Nussenzweig MC
    J Virol; 2019 Apr; 93(8):. PubMed ID: 30700598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cells producing residual viremia during antiretroviral treatment appear to contribute to rebound viremia following interruption of treatment.
    Aamer HA; McClure J; Ko D; Maenza J; Collier AC; Coombs RW; Mullins JI; Frenkel LM
    PLoS Pathog; 2020 Aug; 16(8):e1008791. PubMed ID: 32841299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-depth single-cell analysis of translation-competent HIV-1 reservoirs identifies cellular sources of plasma viremia.
    Cole B; Lambrechts L; Gantner P; Noppe Y; Bonine N; Witkowski W; Chen L; Palmer S; Mullins JI; Chomont N; Pardons M; Vandekerckhove L
    Nat Commun; 2021 Jun; 12(1):3727. PubMed ID: 34140517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 latent reservoir size and diversity are stable following brief treatment interruption.
    Salantes DB; Zheng Y; Mampe F; Srivastava T; Beg S; Lai J; Li JZ; Tressler RL; Koup RA; Hoxie J; Abdel-Mohsen M; Sherrill-Mix S; McCormick K; Overton ET; Bushman FD; Learn GH; Siliciano RF; Siliciano JM; Tebas P; Bar KJ
    J Clin Invest; 2018 Jul; 128(7):3102-3115. PubMed ID: 29911997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Approaches to Multi-Parametric HIV-1 Genetics Using Multiple Displacement Amplification: Determining the What, How, and Where of the HIV-1 Reservoir.
    Patro SC; Niyongabo A; Maldarelli F; Kearney MF
    Viruses; 2021 Dec; 13(12):. PubMed ID: 34960744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between intact HIV-1 proviruses in circulating CD4
    Lu CL; Pai JA; Nogueira L; Mendoza P; Gruell H; Oliveira TY; Barton J; Lorenzi JCC; Cohen YZ; Cohn LB; Klein F; Caskey M; Nussenzweig MC; Jankovic M
    Proc Natl Acad Sci U S A; 2018 Nov; 115(48):E11341-E11348. PubMed ID: 30420517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Residual Proviral Reservoirs: A High Risk for HIV Persistence and Driving Forces for Viral Rebound after Analytical Treatment Interruption.
    Wang X; Xu H
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33670027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotypic and Phenotypic Diversity of the Replication-Competent HIV Reservoir in Treated Patients.
    Nicolas A; Migraine J; Dutrieux J; Salmona M; Tauzin A; Hachiya A; Estaquier J; Molina JM; Clavel F; Hance AJ; Mammano F
    Microbiol Spectr; 2022 Aug; 10(4):e0078422. PubMed ID: 35770985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Proviral DNA in Circulating Cells Correlates with Plasma Viral Rebound in Simian Immunodeficiency Virus-Infected Rhesus Macaques after Antiretroviral Therapy Interruption.
    Ziani W; Shao J; Wang X; Russell-Lodrigue K; Liu YZ; Montaner LJ; Veazey RS; Xu H
    J Virol; 2021 Feb; 95(6):. PubMed ID: 33408173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Origin of Rebound Plasma HIV Includes Cells with Identical Proviruses That Are Transcriptionally Active before Stopping of Antiretroviral Therapy.
    Kearney MF; Wiegand A; Shao W; Coffin JM; Mellors JW; Lederman M; Gandhi RT; Keele BF; Li JZ
    J Virol; 2016 Feb; 90(3):1369-76. PubMed ID: 26581989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early Emergence and Long-Term Persistence of HIV-Infected T-Cell Clones in Children.
    Bale MJ; Katusiime MG; Wells D; Wu X; Spindler J; Halvas EK; Cyktor JC; Wiegand A; Shao W; Cotton MF; Hughes SH; Mellors JW; Coffin JM; Van Zyl GU; Kearney MF
    mBio; 2021 Apr; 12(2):. PubMed ID: 33832973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The forces driving clonal expansion of the HIV-1 latent reservoir.
    Liu R; Simonetti FR; Ho YC
    Virol J; 2020 Jan; 17(1):4. PubMed ID: 31910871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VIP-SPOT: an Innovative Assay To Quantify the Productive HIV-1 Reservoir in the Monitoring of Cure Strategies.
    Puertas MC; Bayón-Gil Á; Garcia-Guerrero MC; Salgado M; Urrea V; Morón-López S; Peña R; Jiménez-Moyano E; Clotet B; Prado JG; Martinez-Picado J
    mBio; 2021 Jun; 12(3):e0056021. PubMed ID: 34154408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterizing the Latent HIV-1 Reservoir in Patients with Viremia Suppressed on cART: Progress, Challenges, and Opportunities.
    Rausch JW; Le Grice SFJ
    Curr HIV Res; 2020; 18(2):99-113. PubMed ID: 31889490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal clonal dynamics of HIV-1 latent reservoirs measured by combination quadruplex polymerase chain reaction and sequencing.
    Cho A; Gaebler C; Olveira T; Ramos V; Saad M; Lorenzi JCC; Gazumyan A; Moir S; Caskey M; Chun TW; Nussenzweig MC
    Proc Natl Acad Sci U S A; 2022 Jan; 119(4):. PubMed ID: 35042816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phospholipid Metabolism Is Associated with Time to HIV Rebound upon Treatment Interruption.
    Giron LB; Papasavvas E; Yin X; Goldman AR; Tang HY; Palmer CS; Landay AL; Li JZ; Koethe JR; Mounzer K; Kostman JR; Liu Q; Montaner LJ; Abdel-Mohsen M
    mBio; 2021 Feb; 12(1):. PubMed ID: 33622719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A minor population of macrophage-tropic HIV-1 variants is identified in recrudescing viremia following analytic treatment interruption.
    Andrade VM; Mavian C; Babic D; Cordeiro T; Sharkey M; Barrios L; Brander C; Martinez-Picado J; Dalmau J; Llano A; Li JZ; Jacobson J; Lavine CL; Seaman MS; Salemi M; Stevenson M
    Proc Natl Acad Sci U S A; 2020 May; 117(18):9981-9990. PubMed ID: 32300019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of integration and clonal expansion in HIV infection: live long and prosper.
    Anderson EM; Maldarelli F
    Retrovirology; 2018 Oct; 15(1):71. PubMed ID: 30352600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.